Category Archives: Corporate

Latest From Corporate

Insurers and Hospital Industry Caught Spreading More “False Alarms”

new-bio-logo

Yet again, Big Insurance and its allies have been caught making claims that are just not true. It began with an op-ed from America’s Health Insurance Plans (AHIP) President Marilyn Tavenner and American Hospital Association President (AHA) Rick Pollack in The Hill trying to blame others for ever-increasing  insurance premiums. Next, they tried to suggest drug costs are to blame for skyrocketing hospital costs. The study was funded by both the American Hospital Association and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Oxford Union Debate Remarks

new-bio-logo

Remarks of BIO CEO Jim Greenwood As prepared for delivery. Oxford Union Debate Oxford, England Thursday, October 20, 2016 Mr. Chairman, thank you for the invitation to be here this evening. It is, indeed, a great honor. For 182 years, the Oxford Union has shown the world what civil discourse looks like. I wish I could say the same about this year’s U.S. presidential campaign. I began my career working with children who had intellectual Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: ,

Harvard Launches New Campaign to End Insurance Discrimination

Be.Futureproof

Earlier this year, BIO launched our Value Campaign. One of the main goals of this effort is to shine a spotlight on the insurance industry’s efforts to restrict patients’ access to the medications they need. For years, the insurance industry and its allies have made patients pay more for less coverage. That’s just plain wrong. In the post-Affordable Care Act (ACA) age, insurers—banned from  excluding patients with pre-existing conditions—have taken to more creative means to Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

Insurers Still Spreading Falsehoods To Protect Their Bottom Line

Drugs

For the better part of a year, BIO has been on a mission to shine a light on the insurance industry and what they and their allies do to restrict patient access to innovative breakthroughs. Apparently, we’re not the only ones who’ve caught on to the falsehoods spread by insurers to protect their bottom line. Kaiser Health News’ Chad Terhune says Consumers Union has taken aim at two California Blue Cross Blue Shield insurers who Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

New Study Debunks Myths About Orphan Drug Act and Rare Disease Drug Costs

Be.Futureproof

The Orphan Drug Act has been targeted recently by the insurance industry and its allies in the media, but in the face of withering criticism and unjustified allegations, a new study from IMS Health shows that concerns about rare drug costs are completely misguided. Kaiser Health News’ Sarah Jane Tribble reports the study, published in Health Affairs, “analyzed U.S. pharmaceutical spending from 2007 to 2013 on more than 300 drugs that had orphan approval under Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: ,